Determining whether hexanucleotide G4C2 transcripts recruit the ribosome following the canonical translation initiation or using an IRES mechanism is a crucial step for the development of therapeutic approaches targeting RAN translation in C9ORF72 ALS/FTD patients. This evidence concerns the gene RAN and frontotemporal dementia.